Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10570151
Biologically active molecules, conjugates thereof, and therapeutic uses
granted -
US 10570382
Transposase polypeptides and uses thereof
granted -
US 10568919
Composition for lowering blood lipids and use thereof
granted -
US 10570092
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 10570120
Neprilysin inhibitors
granted -
US 10568956
Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
granted -
US 10568844
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules
granted -
US 10570214
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 10568963
Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles
granted -
US 10568880
Glucocorticoid receptor modulators to treat cervical cancer
granted -
US 10570393
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 10570452
Method of predicting a predisposition to QT prolongation
granted -
US 10570419
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10570453
Method of predicting a predisposition to QT prolongation
granted -
US 10570418
Methods and compositions for RNA-directed target DNA modification
granted -
US 10570401
Compositions and method for destabilizing, altering, and dispersing biofilms
granted -
US 10570391
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
granted -
US 10570186
Chimeric antigen receptors (CAR) to selectively target protein complexes
granted -
US 10570169
Conjugated antisense compounds and their use
granted -
US 10570153
Benzodiazepine derivatives as RSV inhibitors
granted -
US 10570185
Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
granted -
US 10570183
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 10570172
Self-assembling amphiphilic peptides
granted -
US 10570126
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.